chrisvoncsefalvay/vaers-outcomes huggingface dataset:
REPORTS EXPERIENCING EXCESSIVE FATIGUE, SEVERE MUSCLE ACHES, RESTRICTION TO MOVEMENT TO LEFT ARM, NAUSEA, DIZZINESS, BLURRED VISION.  REPORTS TAKING SOME OTC TYLENOL 800MG PO TO ALLEVIATE ACHES AND EATING SOMETHING  (BANANA AND ORANGE JUICE) .
t102, vomiting, fever blisters beginning 730PM 6JUn95;
tiredness; soreness; couldn't stop shaking uncontrollably; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PAIN (soreness) and TREMOR (couldn't stop shaking uncontrollably) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness), PAIN (soreness) and TREMOR (couldn't stop shaking uncontrollably). At the time of the report, FATIGUE (tiredness), PAIN (soreness) and TREMOR (couldn't stop shaking uncontrollably) outcome was unknown.            Patient wants to know if this is a normal side effect.   This case was linked to MOD-2021-065477, MOD-2021-065477 (Patient Link).
Breakthrough case admission after 2 vaccines PFizer 11/2/21 Lot# 32830BD;  Pfizer 11/23/21 Lot# FH8030
soreness in arm, lump, hot to touch, itchy, left arm tingly and numb
Information has been received from a physician concerning a female patient who in April 2009 was vaccinated with GARDASIL (dose unspecified). The reporter mentioned that after vaccination the patient experienced seizures. The physician stated that the patient received the dose of GARDASIL and then sometime after called the office and wanted to know if there were any correlations between getting GARDASIL vaccine and having seizures. The physician did not believe that there was any correlation but he is not sure. The patient sought unspecified medical attention. The patient's outcome was not reported. Upon internal review, seizure was considered an other important medical event. Additional information has been requested.
I received my Moderna second dose vaccine on 02-11-2021. On Day 3; I experienced dizziness that I lost consciousness in my bathroom. On the 4th day, my body was hurting all over. I also experienced soreness at the injection site.
Stiffness and soreness in left arm within 60 min. The next day, woke up with chills, pain in muscles, bones, joints, etc.
Received flu vaccine on 11/27/2018. Pain in right arm after injection. Right lower arm distal to antecubital fossa ventral aspect 3.5 x 4 cm area of ecchymosis, mildly tender to touch. Also area proximal to wrist ulnar aspect 2 x 3 cm area of mild erythema, tender to palpation. Right hand strength decreased compared to left.
After developing a fever (lasted two days), my very regular period (tracked consistently for 7 years) was not regular after vaccination with a booster dose of Moderna following Pfizer as the primary vaccination series. I missed an entire ovulation cycle (no chance of pregnancy/miscarriage); then the second period after vaccination came much sooner than anticipated (26 days) when my cycle is usually 33 days long. No other concurrent illnesses or confounding variables. In 7 years of tracking, my cycle has never been off more than one or two days let alone an entire cycle. I used the tracking to get pregnant on my first try/cycle years ago. I know my period tracking is accurate and the COVID-19 vaccine/my immune systems response to it/my body thinking I was ill delayed my ovulation/period.
Patient received FLUMIST on 10-9-08, but still tested positive for A and B influenza on 12-7-08.
Information has been received from a physician concerning a 14 year old female who on 18-JUL-2007 was vaccinated with a dose of Gardasil. Concomitant therapy included Menactra. On 18-JUL-2007 the patient fainted after vaccination with Gardasil while still in the office. Unspecified medical attention was sought. On 18-JUL-2007 the patient recovered. Additional information has been requested.
felt bad; my stomach is not right; pains in the upper stomach; sore joints; ran fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), ABDOMINAL DISCOMFORT (my stomach is not right), ABDOMINAL PAIN UPPER (pains in the upper stomach), ARTHRALGIA (sore joints) and PYREXIA (ran fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt bad), ARTHRALGIA (sore joints) and PYREXIA (ran fever). an unknown date, the patient experienced ABDOMINAL DISCOMFORT (my stomach is not right) and ABDOMINAL PAIN UPPER (pains in the upper stomach). At the time of the report, FEELING ABNORMAL (felt bad), ABDOMINAL DISCOMFORT (my stomach is not right), ABDOMINAL PAIN UPPER (pains in the upper stomach), ARTHRALGIA (sore joints) and PYREXIA (ran fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: unknown Pyrexia.         Concomitant medications were not reported. Treatment details were not reported. Body temperature assessment was not given.
I have had daily heart palpitation and a racing heart.  I think I may have had a heart attack.  I have no insurance so was unable to get care.   I have not had hot flashes in years and now m suffering those daily as well.  I have had major fatigue and almost a vertigo feeling .
8 cm x 5 cm cellulitis (L) upper, outer arm hours following injection. Rx: cephalexin 500 mg BID x 10 days.
administered Anthrax the last week of January that expired December 2018; No adverse reactions; Received a spontaneous report on 05MAR2019.  The patient who traveled overseas, reported that a patient was administered Anthrax the last week of January that expired December 2018. A patient safety report was filled out and the incident was reported to VAERS. Patient displayed no adverse reactions. Policy changes were made to ensure lot numbers and expiration dates are checked prior to administration.  No further information is expected.
BODY BASICALLY WENT ON A 2 DAY VACATION BOTH TIMES, FELT AS IF HE WAS GLUED TO THE FLOOR; ARM WAS A LITTLE SORE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On an unspecified date, the patient experienced body basically went on a 2 day vacation both times, felt as if he was glued to the floor, and arm was a little sore. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body basically went on a 2 day vacation both times, felt as if he was glued to the floor and arm was a little sore was not reported. This report was non-serious.
pt recvd vax & quit breathing; had sz 4 days after vax given; went to er;
Allergy to penicillin, reaction unknown. 30 minute observation. OC, NP.   While resting in Obs pt c/o of nausea and feeling sick, diaphoretic and sent to med eval #2 for further evaluation.  C/o of HA since this am Hx of HA.  Lying down, fluids offered. Ice pack and cold water declined.  Resting.  Pt dry heaving and vomited his entire breakfast approx. 1liter yellow fluid.  Denies any further HA or nausea, feeling much better after taking po fluids, declines electrolyte water.  Pt fiancé works in mall and feels better will stop by to visit her.  Discussed further symptoms persist contact PMD, rest, fluids  Reviewed next dose and to have clear liquids prior to vaccine and drink plenty of water.  Verbalized understanding.  Discharged ambulatory at 1435.
inappropriate schedule of vaccine administration; inappropriate schedule of vaccine administration; This spontaneous report has been received from a lawyer, from a case in litigation for zoster vaccine live (ZOSTAVAX) (MARRS # 1810USA005788), concerning a 54-year-old female patient.  On 01-JAN-2005 and 15-OCT-2006, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (reported as pneumococcal polysaccharide PPV23) (manufacturer unknown) (strengths, doses, routes, anatomical locations, lot numbers and expiration dates were not reported) as prophylaxis (inappropriate schedule of product administration).  On 13-JAN-2017, the patient was vaccinated with pneumococcal vaccine conj 13V (CRM197) (reported as pneumococcal conjugated PCV 13) (manufacturer unknown) (strength, dose, route, anatomical location, lot number and expiration date were not reported) as prophylaxis; then, on 17-JUL-2017, the pt received another dose of pneumococcal vaccine, polyvalent (23-valent) (reported as pneumococcal polysaccharide PPV23) (manufacturer unknown) (strength, dose, route, anatomical location, lot number and expiration date were not reported) as prophylaxis (inappropriate schedule of product administration).; Sender's Comments:  US-009507513-1810USA005788:
A report was received from a health care professional via another company concerning a 38 year old female vaccinee. On 10/16/06 the vaccinee was administered an Influenza vaccine in her right arm and Pneumovax 23, 0.5ml IM in her left arm. By th evening of 10/16/06, the vaccinee had developed discomfort in her left arm with progressive difficulty in moving it. The injection site was also red painful and tender. On 10/17/06 the left arm discomfort continued, the arm became red and the vaccinee was unable to raise the arm. The vaccinee had also developed a temp of 10.F, sweats and a headache. There were no problems with the right arm at the site of influenza vaccination. On 10/18/06 the vaccinee started vomiting, a CBC was performed, and the vaccinee was called in for examination when the results were returned at 18K. Physical examination on 10/18/06 revealed a temp of 103.3, pulse 130, pulse OX 98, blood pressure 122/70 and a respiratory rate of 14. The vaccinee was diaphoretic, and tachycardia was confirmed. The skin was remarkable for tenderness and a 6cm patch of erythema at the injection site and another 2cm patch of erythema nearby. Investigations revealed a WBC of 18.1 with 85.7% neutrophils and leukocytosis. It was reported that the vaccinee had a febrile reaction to Pneumovax 23 vaccination and that a secondary infection at the injection site could not be ruled out. the vaccinee was commenced on Keflex. the vomiting was considered secondary and was to be treated with Phenegran. On 10/19/06, the vaccinee had a fever of 101\4F, continued vomiting, leukocytosis and a swollen arm. the vaccinee was admitted to hospital on 10/19/06 for left shoulder redness and tenderness consistent with cellulitis. As the symptoms were progressing it was considered that the Cephalexin was not working, so the vaccinee was commenced on IV Clindamycin and Vancomycin. The affected area was now 9x12 and the secondary smaller area was 3cm. the vaccinee white cell count on admission was 22000, T max 101.7 at 1:+1, pulse 105, RR 16, blood pressure 118/73 and oxygen Saturation 99% on room air. Ultrasound of the upper extremity on 10/20/06 showed no evidence of fluid collection or foreign body. As of 10/20/06 the redness had spread a little further but induration and inflammation was reduced. There was no axillary lymphadenopathy, no streaking, and the vaccinee could move her arm more freely. The white cell count was down to 18000, hematocrit down from 35 to 30, glucose 125 and UA showed a specific gravity of 1.031, greater than 300 protein and she remained afebrile from 10/19/06. Incidental findings were a hematocrit of 30 with a MCV of 91 post hydration probably consistent with iron deficiency anemia. The reporter considered the events to serious  other medical event (OMIC). The vaccinee recovered.
Severe headache almost to a migraine on day 2 and 3.; Severe headache almost to a migraine on day 2 and 3.; Extreme tiredness on first day; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 24Apr2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), high cholesterol, depression, hypothyroidism and lactose intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications and it was reported as too many to be listed. On 24Apr2021, on the first day of vaccination, the patient experienced extreme tiredness. On 25Apr2021 and 26Apr2021, on days 2 and 3, the patient had severe headache almost to a migraine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme tiredness and severe headache almost to a migraine was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
swelling in the wrist, hand, fingers; swelling in the wrist, hand, fingers; muscle soreness in the left arm and difficulty in the lifting; muscle soreness in the left arm and difficulty in the lifting; soreness in shoulder, upper left quadrant, back, neck; soreness in shoulder, upper left quadrant, back, neck; achy injection site/throbbing in left arm where she got the vaccine; soreness in the upper arm, in the forearm; throbbing and tingling in left arm where she got the vaccine; achy elbow 3 hours after the injection.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 40; Unit: Unknown) received BNT162B2 (Pfizer-Biontech covid-19 vaccine, Solution for injection, Lot number: EL3247, exp date not reported), via an unspecified route of administration on 28Jan2021 08:25 for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient wanted to report a reaction that she had after receiving the Pfizer covid vaccine. She said she received the vaccine on site (not specified). On 28Jan2021, after receiving the vaccine she had achy injection site, soreness in the upper arm, in the forearm; throbbing and tingling in left arm where she got the vaccine; and achy elbow 3 hours after the injection. She said around 3 PM, she had swelling in the wrist, hand, and fingers; she had to remove the ring she was wearing. She also experienced muscle soreness in the left arm and difficulty in the lifting; soreness in shoulder, upper left quadrant, back, neck. Patient took ibuprofen for the events. The events improved over night and she just have some soreness the day of reporting.
Migraine, Nausea,hives, Slept 20 hours out of 24, vomiting, diarrhea, felt heavy medicated for several days,confusion, heart flutters
About 40 minutes after giving the vaccines patient developed hives around the eyes some on cheeks. No respiratory problems advised to go to ER given EPIPEN and DECADRON and observed for 3 hours. Stable and sent home on Prednisone x 4 days and BENADRYL as needed. F/up visit done in the office 9-28-10 patient is doing fine, no more hives, stable.
pt recvd vax 2FEB93 & 16FEB93 devel pain, swelling & a lump @ the inject site; seen by MD who stated that it was nl; pt recovered 1 day later; seen by MD 2 wks later w/no noted problems;
I DIDN'T DILUTE THE VACCINE. PT CURRENTLY DOESN'T HAVE SYMPTOMS.
Tachycardia with first dose on Dec 17, then, with 2nd dose experienced off and on tachycardia and also irregular rhythm , no other cardiac related sequels .  Second dose, 1/7/21, experienced fever on 1/8/21 of 101.6 off and on that day.   Used mainly Advil and Tylenol for fever and headache.
PT STATES SHE HAD A Tdap ADMINISTERED IN LEFT ARM ON 2/25/10 AND EVER SINCE A SUBSTANCE HAS BEEN SECRETING FROM THE INJECTION SITE. DENIES REDNESS, BUT HAS A NODE AND PAIN. PER PATIENT THE SECRETION HAS A SMELL LIKE 'MOTOR OIL'.
Fever - 100 degrees.  Severe chills.  Profuse sweating.  Red gummy eyes.  Trouble taking deep breaths.  Took TheraFlu night time.  Woke with 101 fever at 6:30 AM.  Currently running 101 fever at 8:00 AM.  Eyes bloodshot.  Weak body aches.
Vaccinated approximately 11:30 am - Noon.  By evening, injected arm very sore, shoulder to hand (could barely lift arm).  Next morning, experienced dizziness and vomiting.  Felt bad most of day.  Better in the evening.  Temperature was normal.  Pounding headache.
bad watery diarrhea and 6 loose stools per day; sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (bad watery diarrhea and 6 loose stools per day) and VACCINATION SITE PAIN (sore right injection site arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Aug-2021, the patient experienced DIARRHOEA (bad watery diarrhea and 6 loose stools per day) and VACCINATION SITE PAIN (sore right injection site arm). At the time of the report, DIARRHOEA (bad watery diarrhea and 6 loose stools per day) and VACCINATION SITE PAIN (sore right injection site arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided. No treatment medications were provided.    This case was linked to MOD-2021-323763 (Patient Link).
1st vaccination given in left arm on 5/1/2021 2nd vaccination given in right arm on 5/29/2021  I noticed my hair falling out a week or 10 days before getting a 2nd dose.
Pt recvd flu vax 7NOV91 230PM & @ 235PM voice turned raspy difficulty breathing, felt bronchial constriction & h/a; 08NOV91 awoke w/t103, unable to move lt arm, secondary pain in joints & swollen lymph nodes (golf ball size); lasted 3 days;
The left side of her face, it didn't go completely numb, but mostly; still can't chew on the side of the mouth; difficulty speaking; her eye socket, it didn't feel like her eye was there; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK923, expiration date: Apr2021), via unknown route of administration on 30Dec2020 at single dose (first dose by injection once to left upper arm, by the shoulder, a little down) for COVID-19 immunization. Medical history included ongoing high blood pressure. Concomitant medications were reported none. Her blood pressure was diagnosed years prior to the report, like 10+ years prior to the report, but she did not know if it had anything to do with it. The left side of her face, it didn't go completely numb on 30Dec2020, but mostly: stated her eye socket, it didn't feel like her eye was there, and her mouth, she had difficulty speaking, she still could not chew on the side of the mouth in Dec2020. Stated it felt like pulling, like something pulling, like a rope was tied and pulling backwards to the back of head and downward. States this lasted 2 days thankfully, and she did not regret getting it. She Provided weight as a lot of pounds, said she was joking. The vaccine was not prescribed by a doctor, her job offered it, she worked at a hospital, so it was voluntary and she took it. The event started maybe 6 hours after getting the vaccine, it was while she was sleeping, she woke up, she had slept, it was in the middle of the night, and was gone by Saturday for sure. This was her first dose. States site of administration was where she typically gets flu shots. The outcome of the event The left side of her face, it didn't go completely numb was recovered on 02Jan2021. The outcome of other events was unknown.
1st Shingrix vaccine 3 years ago.Never rec'd the 2nd.; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. The patient never received 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient asked if it was too late to get the 2nd dose. No further information was reported.
Information was received from a certified nurse assistant regarding a 12 year old male patient who was administered GARDASIL (lot # J008423) injection intramuscular 0.5ml in left deltoid on 05AUG2014. The GARDASIL was involved in a temperature excursion. No adverse event was reported. Additional information is not expected.
No Adverse event; Patient received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 61-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose). No concomitant medications were reported. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment information was provided.